Article Archives - Page 2 of 5

Transformation in Trials: Becky Baggett on the Science and Strategy Behind Successful Clinical Trials

Tune in to hear Becky Baggett, Rho’s Associate Vice President of Project Delivery, navigate the world of clinical trials by “unraveling the complexities and enlightening us on the crucial collaboration between the sponsor and the CRO, the importance of clinical research sites, data management, and project management. She underscores the absolute necessity of establishing solid relationships, trust, and experience in this highly controlled and regulated field.”

Applied Clinical Trials and Pharmaceutical Executive Feature Rho Regulatory Experts’ Article: The EU Regulations Catching US Pharma Companies Off Guard

Rho’s Anna Pinsky, MD, PhD, Medical Director, and Elina Smirnova, Associate Director of Start Up Services Europe are featured in Applied Clinical Trials as they take a deep dive into the European regulatory landscape and share their insights on how US Sponsors can keep their European clinical trials on schedule and within budget.

RARECast Podcast Features Rho’s Jamie Chang, M.D.: Considering the Unfinished Work in Cystic Fibrosis

triangle business journal best places to work award

Rho Awarded 2023 Best Places to Work

Rho has once again been chosen as a winner of Triangle Business Journal’s 2023 Best Places to Work Awards. This is the 11th year Rho has been recognized for the Triangle Business Journal’s award “a prestigious award that honors companies for creating policies and a work environment that employees value.”

One of the most rewarding aspects of this recognition is that it is driven by employee surveys, which are then tabulated and ranked by Quantum Workplace. Rho is honored and proud to receive high marks in areas such as team effectiveness, trust with co-workers, manager effectiveness and work engagements from our employees.

Pharmacies May Hold the Key to Increasing Diversity in Clinical Trials

Rho Receives 2023 CRO Leadership Award

Rho received Clinical Leader and Life Science Leader’s 2023 CRO Leadership award, marking a long history as an award recipient. Forty-six CROs were evaluated on more that 20 different performance metrics. Respondents evaluated companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with CROs and clear experiential data.

Rho was recognized for Exceeding Customer Expectations in Compatibility and Quality and received 4 Individual Attribute Awards in Data Quality, Technology for Real Time Access to Data, Therapeutic Expertise and Operational Excellence.

Drug Discovery World Podcast Features Rho’s Dr. Michael Pace: How Precision Medicine Will Transform Clinical Trials

Contract Pharma Features Amanda Mathis: 3 Important Questions to Ask Before Starting a Clinical Pharmacology Program

Applied Clinical Trials Features Michael Pace: The Benefits and Limitations of Clinical Data Platforms

Overcoming the Complex Challenges in Schizophrenia Trials

Schizophrenia is a disabling, lifelong disease that is difficult to diagnose and treat due to its complexities and challenges. These same intricacies and complications are a critical part of clinical trial development that require a deep understanding of the disease and how to mitigate the anticipated challenges during trial design necessary to advance treatment without delaying study timelines. we discuss how to overcome three of the most complex challenges of any Schizophrenia trial:
Assessments and Scales. Raters and Site Management, and Recruitment and Retention.

Explore Article

Find what matters to you